EU approval boosts Bimzelx’s profile as innovative interleukin-17 inhibitor therapy: GlobalData Read more
European Commission approves Pfizer’s Cibinqo to treat adults with moderate-to-severe atopic dermatitis Read more
European Commission approves Roche’s Gavreto to treat adults with RET fusion-positive advanced non-small cell lung cancer Read more